Urologix, Inc.
OTC: ULGX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Bryon Merade
- Employees
- 61
- Headquarters
- Minneapolis, United States
- IPO year
- 1996
- Market cap
- $2.2K
- Website
- https://www.urologix.com
Loading ULGX…
Loading profile data…Frequently asked questions about ULGX
What does Urologix, Inc. (ULGX) do?
Established in 1991 and headquartered in Minneapolis, Minnesota, Urologix, Inc. specializes in the development, production, promotion, and distribution of minimally invasive medical devices across the United States. The company's innovative solutions target the treatment of obstructions and related symptoms caused by benign prostatic hyperplasia...
Where does ULGX trade?
Urologix, Inc. (ULGX) trades on the Other OTC.
What sector is ULGX in?
Urologix, Inc. (ULGX) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Urologix, Inc.?
Bryon Merade is the chief executive officer of Urologix, Inc. (ULGX).
Where is Urologix, Inc. headquartered?
Urologix, Inc. is headquartered in United States.
Does ULGX pay a dividend?
Urologix, Inc. (ULGX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ULGX go public?
Urologix, Inc. (ULGX) completed its initial public offering in 1996.